Results 71 to 80 of about 788,607 (367)
Molecular Oncology, EarlyView.This study simultaneously investigated circulating tumor cells (CTCs) and exosomes from small‐cell lung cancer (SCLC) patients. The elevated expression of JUNB and CXCR4 in CTCs was a poor prognostic factor for SCLC patients, whereas exosomal overexpression of these biomarkers revealed a high discrimination ability of patients from healthy individuals,
Dimitrios Papakonstantinou +13 more
wiley +1 more source
Mucin-inspired, high molecular weight virus binding inhibitors show biphasic binding behavior to influenza A viruses [PDF]
arXiv, 2020 Multivalent virus binding inhibitors are a promising new class of antivirals, preventing virus infection of cells by inhibiting the first step in the viral infection cycle - binding of viruses to the cell surface. The design of multivalent virus binding inhibitors is complex as many properties, such as inhibitor size and functionalization with virus ...
arxiv
Understanding corrosion inhibition with van der Waals DFT methods: the case of benzotriazole [PDF]
Faraday Discuss. (2015) 180, 439-458, 2015 The corrosion of materials is an undesirable and costly process affecting many areas of technology and everyday life. As such, considerable effort has gone into understanding and preventing it. Organic molecule based coatings can in certain circumstances act as effective corrosion inhibitors.
arxiv +1 more source
TH Open, 2018 Rivaroxaban and apixaban are both small molecules that reversibly inhibit factor Xa. Compared with rivaroxaban, apixaban has minimal effects on the prothrombin time and activated partial thromboplastin time.
Paul Y. Kim +7 more
doaj +1 more source
Comparing Direct Factor Xa Inhibitors and Warfarin in the Prevention of Stroke in Patients with Atrial Fibrillation [PDF]
, 2016 Objective: To evaluate the overall efficacy, advantages, and disadvantages of treatment with direct factor Xa inhibitors as compared to warfarin in the prevention of stroke in patients with atrial fibrillation.
Lof, Alessandra, Pillai, Stephanie
core +1 more source
Cochrane Database of Systematic Reviews, 2018 BACKGROUND Factor Xa inhibitors and vitamin K antagonists (VKAs) are now recommended in treatment guidelines for preventing stroke and systemic embolic events in people with atrial fibrillation (AF).
K. B. Bruins Slot, E. Berge
semanticscholar +1 more source
Advanced Materials, EarlyView.Reversible protonic ceramic electrochemical cells (R‐PCECs) face challenges from sluggish and unstable oxygen reduction and evolution reactions in the air electrode. This review discusses recent progress in triple‐conducting air electrodes, emphasizing mechanisms, performance factors, and design strategies, offering guidance for creating efficient and ...
Xi Chen +8 more
wiley +1 more source
Direct Factor Xa Inhibitors Versus Warfarin in Non-Valvular Atrial Fibrillation: Efficacy, Safety, Cost, and Reversibility [PDF]
, 2016 Atrial fibrillation is a common cause for stroke. Vitamin K antagonists such as warfarin are an effective prophylactic medication to prevent stroke in patients with atrial fibrillation.
Jacobs, Cory D.
core +1 more source
Adjusting Cell‐Surface Interactions Through a Covalent Immobilization of Biomolecules
Advanced Materials Interfaces, EarlyView.This review presents an overview of current and emerging immobilization techniques coupled with an in‐depth investigation of the underlying mechanisms governing the activity and stability of covalently immobilized biomolecules. The aim of this study is to serve as a guide for the development of long‐lasting biomedical coatings with versatile biological
Sara Shakibania +2 more
wiley +1 more source
Anti- factor IIa (FIIa) heparin assay for patients on direct factor Xa (FXa) inhibitors [PDF]
, 2020 BackgroundDirect factor Xa (FXa) inhibitors are increasingly prescribed for outpatients, and those transitioning to unfractionated heparin (UFH) for hospital admission are monitored via an anti- FXa assay.
Hanigan, Sarah +4 more
core +1 more source